vs

Side-by-side financial comparison of Mount Logan Capital Inc. (MLCI) and RYTHM, Inc. (RYM). Click either name above to swap in a different company.

Mount Logan Capital Inc. is the larger business by last-quarter revenue ($11.4M vs $10.7M, roughly 1.1× RYTHM, Inc.). Mount Logan Capital Inc. runs the higher net margin — -117.5% vs -127.6%, a 10.2% gap on every dollar of revenue.

180 Degree Capital Corp. is a publicly traded registered closed-end management investment company.

RYTHM, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for rare genetic endocrine and metabolic disorders with high unmet medical needs. It primarily operates in the U.S. market, targeting pediatric and adult patient segments that lack standard effective treatment options.

MLCI vs RYM — Head-to-Head

Bigger by revenue
MLCI
MLCI
1.1× larger
MLCI
$11.4M
$10.7M
RYM
Higher net margin
MLCI
MLCI
10.2% more per $
MLCI
-117.5%
-127.6%
RYM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
MLCI
MLCI
RYM
RYM
Revenue
$11.4M
$10.7M
Net Profit
$-13.4M
$-13.6M
Gross Margin
75.5%
Operating Margin
-97.3%
-121.5%
Net Margin
-117.5%
-127.6%
Revenue YoY
242.0%
Net Profit YoY
44.1%
EPS (diluted)
$-1.64
$-6.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLCI
MLCI
RYM
RYM
Q4 25
$10.7M
Q3 25
$11.4M
$4.0M
Q2 25
$2.0M
Q1 25
$538.0K
Q4 24
$-7.5M
Q3 24
$1.9M
Q2 24
$3.0M
Q1 24
$2.6M
Net Profit
MLCI
MLCI
RYM
RYM
Q4 25
$-13.6M
Q3 25
$-13.4M
$-10.7M
Q2 25
$-7.4M
Q1 25
$-1.6M
Q4 24
$-24.4M
Q3 24
$-18.7M
Q2 24
$-3.0M
Q1 24
$4.2M
Gross Margin
MLCI
MLCI
RYM
RYM
Q4 25
75.5%
Q3 25
34.0%
Q2 25
33.4%
Q1 25
16.7%
Q4 24
Q3 24
11.6%
Q2 24
37.6%
Q1 24
6.4%
Operating Margin
MLCI
MLCI
RYM
RYM
Q4 25
-121.5%
Q3 25
-97.3%
-219.8%
Q2 25
-332.9%
Q1 25
-687.9%
Q4 24
Q3 24
-63.1%
Q2 24
-28.5%
Q1 24
13.6%
Net Margin
MLCI
MLCI
RYM
RYM
Q4 25
-127.6%
Q3 25
-117.5%
-263.8%
Q2 25
-360.4%
Q1 25
-302.2%
Q4 24
324.4%
Q3 24
-964.4%
Q2 24
-99.3%
Q1 24
163.0%
EPS (diluted)
MLCI
MLCI
RYM
RYM
Q4 25
$-6.78
Q3 25
$-1.64
$-5.33
Q2 25
$-3.74
Q1 25
$-0.83
Q4 24
$-24.26
Q3 24
$-17.28
Q2 24
$-3.16
Q1 24
$3.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLCI
MLCI
RYM
RYM
Cash + ST InvestmentsLiquidity on hand
$32.2M
Total DebtLower is stronger
$73.4M
$80.6M
Stockholders' EquityBook value
$131.2M
$13.0M
Total Assets
$1.6B
$106.7M
Debt / EquityLower = less leverage
0.56×
6.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLCI
MLCI
RYM
RYM
Q4 25
$32.2M
Q3 25
Q2 25
$41.0M
Q1 25
$24.4M
Q4 24
Q3 24
$267.0K
Q2 24
$57.0K
Q1 24
$99.0K
Total Debt
MLCI
MLCI
RYM
RYM
Q4 25
$80.6M
Q3 25
$73.4M
$90.6M
Q2 25
$40.6M
Q1 25
$10.6M
Q4 24
Q3 24
$6.2M
Q2 24
$4.6M
Q1 24
Stockholders' Equity
MLCI
MLCI
RYM
RYM
Q4 25
$13.0M
Q3 25
$131.2M
$11.7M
Q2 25
$21.0M
Q1 25
$26.8M
Q4 24
$28.1M
Q3 24
$5.5M
Q2 24
$8.5M
Q1 24
$-5.5M
Total Assets
MLCI
MLCI
RYM
RYM
Q4 25
$106.7M
Q3 25
$1.6B
$115.2M
Q2 25
$69.5M
Q1 25
$45.6M
Q4 24
$54.0M
Q3 24
$39.0M
Q2 24
$39.4M
Q1 24
$40.6M
Debt / Equity
MLCI
MLCI
RYM
RYM
Q4 25
6.19×
Q3 25
0.56×
7.73×
Q2 25
1.94×
Q1 25
0.40×
Q4 24
Q3 24
1.13×
Q2 24
0.54×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLCI
MLCI
RYM
RYM
Operating Cash FlowLast quarter
$-25.6M
$-3.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLCI
MLCI
RYM
RYM
Q4 25
$-3.0M
Q3 25
$-25.6M
$-5.4M
Q2 25
$-8.4M
Q1 25
$-6.7M
Q4 24
$-5.3M
Q3 24
$-1.4M
Q2 24
$-1.8M
Q1 24
$-3.0M
Free Cash Flow
MLCI
MLCI
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-1.8M
Q1 24
$-3.0M
FCF Margin
MLCI
MLCI
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-61.2%
Q1 24
-115.1%
Capex Intensity
MLCI
MLCI
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
MLCI
MLCI
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MLCI
MLCI

Segment breakdown not available.

RYM
RYM

Nonlicensing Revenue$9.5M89%
Cultivation Business Discontinued Operations$1.2M11%

Related Comparisons